| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Testicular Hormones | 131 | 2007 | 188 | 8.390 |
Why?
|
| Anti-Mullerian Hormone | 156 | 2025 | 420 | 6.740 |
Why?
|
| Growth Inhibitors | 108 | 2003 | 375 | 6.110 |
Why?
|
| Glycoproteins | 126 | 2007 | 2200 | 5.340 |
Why?
|
| Mullerian Ducts | 94 | 2019 | 203 | 4.510 |
Why?
|
| Receptors, Peptide | 37 | 2025 | 280 | 3.090 |
Why?
|
| Receptors, Transforming Growth Factor beta | 46 | 2025 | 304 | 2.750 |
Why?
|
| Disorders of Sex Development | 26 | 2008 | 129 | 2.060 |
Why?
|
| Hernia, Diaphragmatic | 24 | 2012 | 244 | 1.900 |
Why?
|
| Testis | 53 | 2013 | 783 | 1.800 |
Why?
|
| Ovary | 30 | 2025 | 965 | 1.550 |
Why?
|
| Ovarian Follicle | 9 | 2022 | 243 | 1.230 |
Why?
|
| Sex Differentiation | 17 | 2007 | 73 | 1.090 |
Why?
|
| Ovarian Neoplasms | 30 | 2023 | 4903 | 0.980 |
Why?
|
| Adrenal Hyperplasia, Congenital | 7 | 2004 | 98 | 0.660 |
Why?
|
| Genitalia | 9 | 2003 | 114 | 0.620 |
Why?
|
| Fertility Agents, Female | 1 | 2018 | 101 | 0.610 |
Why?
|
| Activin Receptors, Type I | 9 | 2016 | 133 | 0.600 |
Why?
|
| Epithelial Cells | 6 | 2016 | 3698 | 0.570 |
Why?
|
| Animals | 214 | 2025 | 168965 | 0.550 |
Why?
|
| Gonadal Dysgenesis | 9 | 2004 | 28 | 0.530 |
Why?
|
| Rats | 92 | 2023 | 23713 | 0.530 |
Why?
|
| Leydig Cells | 8 | 2004 | 55 | 0.510 |
Why?
|
| Collagen Type IV | 1 | 2016 | 125 | 0.510 |
Why?
|
| Meiosis | 4 | 2013 | 326 | 0.500 |
Why?
|
| Proteins | 7 | 2013 | 6001 | 0.490 |
Why?
|
| Mesoderm | 11 | 2013 | 679 | 0.470 |
Why?
|
| Granulosa Cells | 8 | 2025 | 120 | 0.460 |
Why?
|
| DNA-Binding Proteins | 15 | 2014 | 9612 | 0.460 |
Why?
|
| Fetus | 20 | 2005 | 1878 | 0.460 |
Why?
|
| Lung | 31 | 2023 | 10076 | 0.440 |
Why?
|
| Chick Embryo | 11 | 2016 | 973 | 0.440 |
Why?
|
| Recombinant Proteins | 30 | 2013 | 6507 | 0.430 |
Why?
|
| Smad Proteins | 4 | 2016 | 157 | 0.430 |
Why?
|
| Morphogenesis | 2 | 2016 | 746 | 0.430 |
Why?
|
| Cell Division | 22 | 2009 | 4473 | 0.410 |
Why?
|
| DNA Copy Number Variations | 7 | 2024 | 2047 | 0.410 |
Why?
|
| Signal Transduction | 27 | 2025 | 23621 | 0.400 |
Why?
|
| Peptide Hormones | 2 | 2023 | 132 | 0.400 |
Why?
|
| Transforming Growth Factor beta | 9 | 2025 | 1995 | 0.400 |
Why?
|
| Chromosome Aberrations | 5 | 2016 | 1776 | 0.400 |
Why?
|
| Sertoli Cells | 9 | 2013 | 50 | 0.400 |
Why?
|
| Cell Movement | 7 | 2017 | 5203 | 0.390 |
Why?
|
| Abnormalities, Multiple | 12 | 2016 | 1424 | 0.390 |
Why?
|
| Dependovirus | 2 | 2017 | 720 | 0.370 |
Why?
|
| Transcription Factors | 14 | 2018 | 12158 | 0.360 |
Why?
|
| Tumor Cells, Cultured | 26 | 2016 | 6106 | 0.360 |
Why?
|
| Embryo, Mammalian | 7 | 2012 | 1676 | 0.360 |
Why?
|
| Reproduction | 4 | 2020 | 646 | 0.360 |
Why?
|
| Mice | 69 | 2025 | 81912 | 0.350 |
Why?
|
| Peptide Fragments | 7 | 2016 | 5141 | 0.330 |
Why?
|
| Gene Expression Regulation, Developmental | 12 | 2017 | 3610 | 0.330 |
Why?
|
| Diaphragm | 4 | 2016 | 357 | 0.330 |
Why?
|
| Female | 203 | 2025 | 396660 | 0.330 |
Why?
|
| Receptors, Growth Factor | 5 | 2003 | 324 | 0.330 |
Why?
|
| Molecular Sequence Data | 26 | 2014 | 17608 | 0.320 |
Why?
|
| Oogenesis | 2 | 2006 | 125 | 0.320 |
Why?
|
| Animals, Newborn | 18 | 2021 | 2677 | 0.310 |
Why?
|
| Base Sequence | 22 | 2019 | 12414 | 0.310 |
Why?
|
| Contraceptive Agents | 2 | 2022 | 147 | 0.300 |
Why?
|
| Fetal Organ Maturity | 7 | 2001 | 83 | 0.300 |
Why?
|
| Hypospadias | 3 | 2004 | 98 | 0.280 |
Why?
|
| Congenital Abnormalities | 2 | 2010 | 703 | 0.280 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2015 | 3608 | 0.280 |
Why?
|
| Gonads | 6 | 2006 | 109 | 0.280 |
Why?
|
| Genetic Association Studies | 3 | 2016 | 2744 | 0.280 |
Why?
|
| Syndrome | 13 | 2018 | 3271 | 0.280 |
Why?
|
| Neoplastic Stem Cells | 3 | 2016 | 1349 | 0.280 |
Why?
|
| Neoplasms, Gonadal Tissue | 1 | 2006 | 3 | 0.270 |
Why?
|
| Gene Expression Regulation | 14 | 2016 | 11923 | 0.270 |
Why?
|
| Gene Expression Regulation, Neoplastic | 10 | 2017 | 8628 | 0.270 |
Why?
|
| Embryonic and Fetal Development | 6 | 2002 | 420 | 0.270 |
Why?
|
| Amino Acid Sequence | 21 | 2021 | 13411 | 0.260 |
Why?
|
| Androgens | 8 | 2006 | 1281 | 0.260 |
Why?
|
| Hypertelorism | 2 | 2008 | 29 | 0.260 |
Why?
|
| Rats, Inbred Strains | 18 | 1992 | 2078 | 0.260 |
Why?
|
| Phenyl Ethers | 7 | 2023 | 62 | 0.260 |
Why?
|
| Humans | 200 | 2025 | 767040 | 0.260 |
Why?
|
| Vagina | 7 | 1994 | 849 | 0.250 |
Why?
|
| Follicle Stimulating Hormone | 7 | 1994 | 727 | 0.250 |
Why?
|
| Virilism | 4 | 2003 | 28 | 0.250 |
Why?
|
| Oocytes | 7 | 2020 | 1168 | 0.250 |
Why?
|
| Spermatogenesis | 1 | 2006 | 260 | 0.250 |
Why?
|
| Follicular Fluid | 3 | 2021 | 92 | 0.240 |
Why?
|
| Gonadal Steroid Hormones | 6 | 1997 | 707 | 0.240 |
Why?
|
| Stem Cells | 4 | 2008 | 3535 | 0.240 |
Why?
|
| Endometrial Neoplasms | 3 | 2015 | 1381 | 0.240 |
Why?
|
| Hirschsprung Disease | 4 | 1992 | 164 | 0.240 |
Why?
|
| Basement Membrane | 4 | 2016 | 348 | 0.240 |
Why?
|
| Karyotyping | 12 | 2012 | 1176 | 0.230 |
Why?
|
| Cell Proliferation | 10 | 2016 | 10455 | 0.230 |
Why?
|
| In Situ Hybridization | 9 | 2008 | 1892 | 0.230 |
Why?
|
| Cell Adhesion Molecules | 1 | 2010 | 1612 | 0.230 |
Why?
|
| Chromosome Inversion | 1 | 2004 | 119 | 0.230 |
Why?
|
| Doxorubicin | 4 | 2025 | 2229 | 0.230 |
Why?
|
| Tacrolimus Binding Protein 1A | 1 | 2004 | 40 | 0.230 |
Why?
|
| RNA, Messenger | 23 | 2016 | 12793 | 0.230 |
Why?
|
| Failure to Thrive | 1 | 2004 | 139 | 0.220 |
Why?
|
| Male | 158 | 2024 | 364203 | 0.220 |
Why?
|
| Infant, Newborn | 48 | 2023 | 26396 | 0.220 |
Why?
|
| Ovulation | 2 | 2022 | 181 | 0.220 |
Why?
|
| Comparative Genomic Hybridization | 2 | 2018 | 474 | 0.220 |
Why?
|
| Gonadal Dysgenesis, Mixed | 4 | 1994 | 7 | 0.220 |
Why?
|
| Mutation | 16 | 2018 | 30211 | 0.220 |
Why?
|
| Histocompatibility Antigens Class II | 4 | 1992 | 1442 | 0.220 |
Why?
|
| Organ Culture Techniques | 22 | 2008 | 789 | 0.220 |
Why?
|
| Endothelial Cells | 1 | 2016 | 3582 | 0.220 |
Why?
|
| Cattle | 26 | 1998 | 3813 | 0.210 |
Why?
|
| Protein Isoforms | 3 | 2016 | 1716 | 0.210 |
Why?
|
| Myometrium | 4 | 2009 | 174 | 0.210 |
Why?
|
| beta Catenin | 4 | 2017 | 1048 | 0.210 |
Why?
|
| Anthracenes | 3 | 2022 | 83 | 0.210 |
Why?
|
| Diffusion of Innovation | 1 | 2008 | 724 | 0.210 |
Why?
|
| Blotting, Northern | 12 | 2006 | 1550 | 0.210 |
Why?
|
| Apoptosis | 14 | 2025 | 9513 | 0.200 |
Why?
|
| Trachea | 8 | 2005 | 1095 | 0.200 |
Why?
|
| Genome-Wide Association Study | 2 | 2024 | 12790 | 0.200 |
Why?
|
| Gonadotropins | 4 | 2002 | 241 | 0.200 |
Why?
|
| Antigens, Neoplasm | 1 | 2010 | 1997 | 0.200 |
Why?
|
| Rats, Sprague-Dawley | 22 | 2023 | 8108 | 0.200 |
Why?
|
| Phenotype | 8 | 2018 | 16718 | 0.200 |
Why?
|
| Transcription, Genetic | 11 | 2021 | 7611 | 0.200 |
Why?
|
| NF-kappa B | 7 | 2023 | 2493 | 0.200 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2003 | 301 | 0.200 |
Why?
|
| Mice, Knockout | 7 | 2021 | 14476 | 0.190 |
Why?
|
| ATP-Dependent Proteases | 1 | 2021 | 24 | 0.190 |
Why?
|
| Nuclear Proteins | 7 | 2003 | 5794 | 0.190 |
Why?
|
| Dogs | 8 | 1994 | 3834 | 0.190 |
Why?
|
| Larynx | 5 | 2005 | 492 | 0.190 |
Why?
|
| Neoplasms, Glandular and Epithelial | 2 | 2016 | 488 | 0.190 |
Why?
|
| Sex Chromosome Aberrations | 2 | 2001 | 116 | 0.190 |
Why?
|
| Sequence Deletion | 3 | 2010 | 1494 | 0.190 |
Why?
|
| Tooth Abnormalities | 1 | 2021 | 56 | 0.190 |
Why?
|
| Eye Neoplasms | 2 | 1995 | 305 | 0.190 |
Why?
|
| Cell Line, Tumor | 14 | 2017 | 17097 | 0.190 |
Why?
|
| Testosterone | 12 | 2003 | 2490 | 0.190 |
Why?
|
| Fibrinolysin | 4 | 2003 | 130 | 0.190 |
Why?
|
| Promoter Regions, Genetic | 8 | 2007 | 5796 | 0.190 |
Why?
|
| Specialties, Surgical | 1 | 2006 | 391 | 0.190 |
Why?
|
| Craniofacial Abnormalities | 3 | 2021 | 320 | 0.180 |
Why?
|
| Computational Biology | 2 | 2014 | 3567 | 0.180 |
Why?
|
| Cryptorchidism | 8 | 2003 | 153 | 0.180 |
Why?
|
| Y Chromosome | 4 | 1998 | 205 | 0.180 |
Why?
|
| Smad1 Protein | 3 | 2007 | 81 | 0.180 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2008 | 2883 | 0.180 |
Why?
|
| General Surgery | 3 | 2009 | 1720 | 0.180 |
Why?
|
| Recombinant Fusion Proteins | 7 | 2015 | 3738 | 0.180 |
Why?
|
| Cell Line | 22 | 2011 | 15567 | 0.180 |
Why?
|
| Cricetinae | 10 | 2006 | 2415 | 0.180 |
Why?
|
| Muscles | 3 | 2015 | 1576 | 0.180 |
Why?
|
| Esophagus | 6 | 2005 | 1041 | 0.180 |
Why?
|
| Coturnix | 3 | 1984 | 22 | 0.170 |
Why?
|
| Quail | 3 | 1984 | 40 | 0.170 |
Why?
|
| Phosphoproteins | 6 | 2003 | 2448 | 0.170 |
Why?
|
| Osteochondrodysplasias | 1 | 2021 | 183 | 0.170 |
Why?
|
| Uterus | 2 | 2019 | 661 | 0.170 |
Why?
|
| Cystadenocarcinoma | 1 | 1999 | 54 | 0.170 |
Why?
|
| CHO Cells | 8 | 2006 | 1376 | 0.170 |
Why?
|
| Gene Expression | 10 | 2012 | 7587 | 0.170 |
Why?
|
| Genitalia, Female | 5 | 1994 | 146 | 0.170 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2008 | 2457 | 0.170 |
Why?
|
| Germ Cells | 1 | 2004 | 644 | 0.170 |
Why?
|
| Inhibins | 2 | 2021 | 210 | 0.170 |
Why?
|
| Drug Repositioning | 1 | 2022 | 246 | 0.170 |
Why?
|
| Tissue Array Analysis | 3 | 2016 | 545 | 0.170 |
Why?
|
| Antineoplastic Agents | 7 | 2017 | 13650 | 0.170 |
Why?
|
| Regeneration | 1 | 2008 | 1523 | 0.160 |
Why?
|
| Fetal Diseases | 4 | 1999 | 915 | 0.160 |
Why?
|
| Hip Dislocation, Congenital | 1 | 2021 | 225 | 0.160 |
Why?
|
| Eye Abnormalities | 1 | 2021 | 243 | 0.160 |
Why?
|
| Genital Neoplasms, Female | 4 | 1997 | 535 | 0.160 |
Why?
|
| RNA Splicing | 1 | 2003 | 903 | 0.160 |
Why?
|
| Dystocia | 1 | 2018 | 33 | 0.160 |
Why?
|
| Sex Characteristics | 4 | 2002 | 2647 | 0.160 |
Why?
|
| Point Mutation | 2 | 2003 | 1591 | 0.160 |
Why?
|
| Bone Morphogenetic Protein Receptors, Type I | 4 | 2010 | 97 | 0.160 |
Why?
|
| Androgen-Insensitivity Syndrome | 2 | 1997 | 33 | 0.150 |
Why?
|
| Infant | 37 | 2016 | 36485 | 0.150 |
Why?
|
| Graft Survival | 6 | 1991 | 3896 | 0.150 |
Why?
|
| Transfection | 9 | 2006 | 5753 | 0.150 |
Why?
|
| Chromosomes, Human, Pair 1 | 3 | 2010 | 640 | 0.150 |
Why?
|
| Phosphatidylcholines | 4 | 1996 | 405 | 0.150 |
Why?
|
| Heat-Shock Proteins | 3 | 2016 | 792 | 0.150 |
Why?
|
| Mutation, Missense | 3 | 2023 | 2592 | 0.150 |
Why?
|
| Cell Differentiation | 12 | 2025 | 11657 | 0.150 |
Why?
|
| Paraneoplastic Endocrine Syndromes | 1 | 1997 | 29 | 0.150 |
Why?
|
| Sequence Homology, Amino Acid | 4 | 2006 | 2745 | 0.150 |
Why?
|
| Ascites | 2 | 2015 | 336 | 0.140 |
Why?
|
| Genital Neoplasms, Male | 2 | 1997 | 68 | 0.140 |
Why?
|
| Bile Ducts | 3 | 1992 | 288 | 0.140 |
Why?
|
| Bromodeoxyuridine | 2 | 2008 | 310 | 0.140 |
Why?
|
| Sex Determination Analysis | 3 | 1994 | 46 | 0.140 |
Why?
|
| Dexamethasone | 5 | 1997 | 1963 | 0.140 |
Why?
|
| Pediatrics | 3 | 2009 | 3621 | 0.140 |
Why?
|
| Blotting, Western | 11 | 2015 | 5022 | 0.140 |
Why?
|
| Granulosa Cell Tumor | 2 | 1999 | 76 | 0.140 |
Why?
|
| Homeodomain Proteins | 4 | 2012 | 2429 | 0.140 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2000 | 792 | 0.140 |
Why?
|
| Sex Determination Processes | 3 | 2004 | 61 | 0.130 |
Why?
|
| Pregnancy | 34 | 2020 | 30238 | 0.130 |
Why?
|
| Growth Disorders | 1 | 2021 | 635 | 0.130 |
Why?
|
| DNA | 15 | 2012 | 7210 | 0.130 |
Why?
|
| COUP Transcription Factor II | 1 | 2016 | 19 | 0.130 |
Why?
|
| Genetic Variation | 4 | 2024 | 6611 | 0.130 |
Why?
|
| Small Molecule Libraries | 1 | 2022 | 742 | 0.130 |
Why?
|
| Embryo Transfer | 1 | 2020 | 527 | 0.130 |
Why?
|
| Menstrual Cycle | 1 | 2020 | 546 | 0.130 |
Why?
|
| Phthalic Acids | 1 | 2021 | 487 | 0.130 |
Why?
|
| Endometrium | 2 | 2012 | 406 | 0.130 |
Why?
|
| Steroid 17-alpha-Hydroxylase | 5 | 2004 | 99 | 0.130 |
Why?
|
| Immunocompetence | 2 | 1986 | 138 | 0.130 |
Why?
|
| Transferases | 1 | 1996 | 71 | 0.130 |
Why?
|
| Organogenesis | 2 | 2016 | 214 | 0.130 |
Why?
|
| Luteinizing Hormone | 6 | 2003 | 822 | 0.130 |
Why?
|
| Thyrotropin-Releasing Hormone | 4 | 1997 | 139 | 0.130 |
Why?
|
| Estrous Cycle | 2 | 2022 | 65 | 0.130 |
Why?
|
| Alkyl and Aryl Transferases | 1 | 1996 | 89 | 0.130 |
Why?
|
| Tropism | 1 | 2015 | 44 | 0.130 |
Why?
|
| Child, Preschool | 33 | 2018 | 42606 | 0.130 |
Why?
|
| Mitochondrial Proteins | 1 | 2021 | 980 | 0.120 |
Why?
|
| Chimera | 4 | 1999 | 454 | 0.120 |
Why?
|
| Retinoblastoma-Like Protein p130 | 4 | 2015 | 72 | 0.120 |
Why?
|
| Vulvar Neoplasms | 4 | 1992 | 266 | 0.120 |
Why?
|
| Dihydrotestosterone | 4 | 2003 | 195 | 0.120 |
Why?
|
| Chromatography, Affinity | 10 | 2002 | 524 | 0.120 |
Why?
|
| Uterine Cervical Neoplasms | 5 | 2012 | 2038 | 0.120 |
Why?
|
| Nucleic Acid Hybridization | 2 | 2007 | 1305 | 0.120 |
Why?
|
| DNA Damage | 1 | 2025 | 2469 | 0.120 |
Why?
|
| Immunoassay | 1 | 2018 | 744 | 0.120 |
Why?
|
| Perineum | 3 | 1994 | 212 | 0.120 |
Why?
|
| X Chromosome | 2 | 1998 | 819 | 0.120 |
Why?
|
| Penis | 3 | 2002 | 209 | 0.120 |
Why?
|
| Chromosomes, Human, Pair 15 | 2 | 2007 | 361 | 0.120 |
Why?
|
| Myofibroblasts | 1 | 2016 | 230 | 0.120 |
Why?
|
| Epidermal Growth Factor | 6 | 1994 | 697 | 0.120 |
Why?
|
| Acetylcholinesterase | 5 | 1991 | 151 | 0.120 |
Why?
|
| Frameshift Mutation | 1 | 2016 | 392 | 0.110 |
Why?
|
| Cryopreservation | 2 | 2018 | 727 | 0.110 |
Why?
|
| Gestational Age | 15 | 1997 | 3618 | 0.110 |
Why?
|
| Polycystic Ovary Syndrome | 1 | 2018 | 383 | 0.110 |
Why?
|
| Immunoenzyme Techniques | 7 | 2006 | 1697 | 0.110 |
Why?
|
| Hydrocortisone | 3 | 1997 | 1840 | 0.110 |
Why?
|
| Osteoporosis | 1 | 2023 | 1604 | 0.110 |
Why?
|
| Genomics | 2 | 2009 | 5924 | 0.110 |
Why?
|
| Methods | 9 | 1991 | 1065 | 0.110 |
Why?
|
| COS Cells | 4 | 2007 | 1135 | 0.110 |
Why?
|
| Spheroids, Cellular | 1 | 2015 | 328 | 0.110 |
Why?
|
| Pyrophosphatases | 2 | 1984 | 142 | 0.110 |
Why?
|
| Cyclic AMP | 4 | 2004 | 1472 | 0.110 |
Why?
|
| Microarray Analysis | 1 | 2016 | 751 | 0.110 |
Why?
|
| Motor Neurons | 2 | 2010 | 869 | 0.110 |
Why?
|
| Oligospermia | 1 | 2013 | 59 | 0.110 |
Why?
|
| Retinoblastoma-Like Protein p107 | 3 | 2012 | 70 | 0.110 |
Why?
|
| Transgenes | 2 | 2015 | 1014 | 0.100 |
Why?
|
| Genes, Reporter | 4 | 2001 | 1526 | 0.100 |
Why?
|
| Child | 37 | 2010 | 80771 | 0.100 |
Why?
|
| Quality of Health Care | 1 | 2008 | 4306 | 0.100 |
Why?
|
| Polymorphism, Single Nucleotide | 5 | 2024 | 16036 | 0.100 |
Why?
|
| Fibronectins | 3 | 1985 | 722 | 0.100 |
Why?
|
| Fertilization in Vitro | 1 | 2020 | 1303 | 0.100 |
Why?
|
| Trans-Activators | 2 | 2001 | 2856 | 0.100 |
Why?
|
| Coculture Techniques | 1 | 2016 | 1337 | 0.100 |
Why?
|
| Buttocks | 1 | 1992 | 111 | 0.100 |
Why?
|
| Penetrance | 1 | 2014 | 388 | 0.100 |
Why?
|
| Mice, Inbred C57BL | 14 | 2021 | 22361 | 0.100 |
Why?
|
| Clinical Competence | 1 | 2008 | 4859 | 0.100 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 1997 | 733 | 0.100 |
Why?
|
| Gonadotropin-Releasing Hormone | 4 | 1993 | 1149 | 0.100 |
Why?
|
| Menopause | 1 | 2020 | 1655 | 0.100 |
Why?
|
| Genetic Markers | 1 | 2018 | 2602 | 0.100 |
Why?
|
| Genitalia, Male | 4 | 1994 | 87 | 0.100 |
Why?
|
| Cytosol | 2 | 2013 | 885 | 0.090 |
Why?
|
| Bile Duct Diseases | 1 | 1992 | 98 | 0.090 |
Why?
|
| Neoplasms | 6 | 2010 | 22350 | 0.090 |
Why?
|
| Cells, Cultured | 12 | 2016 | 18989 | 0.090 |
Why?
|
| Hand Deformities, Congenital | 1 | 2012 | 175 | 0.090 |
Why?
|
| Tissue Culture Techniques | 2 | 2010 | 287 | 0.090 |
Why?
|
| Graft Rejection | 6 | 1992 | 4498 | 0.090 |
Why?
|
| Pedigree | 4 | 2021 | 4539 | 0.090 |
Why?
|
| Genetic Techniques | 2 | 2009 | 427 | 0.090 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2024 | 18063 | 0.090 |
Why?
|
| Mass Spectrometry | 1 | 2018 | 2201 | 0.090 |
Why?
|
| Pulmonary Surfactants | 3 | 1999 | 169 | 0.090 |
Why?
|
| Chorioallantoic Membrane | 1 | 2010 | 50 | 0.090 |
Why?
|
| Aging | 8 | 2007 | 8729 | 0.090 |
Why?
|
| Uterine Neoplasms | 4 | 2009 | 1424 | 0.090 |
Why?
|
| Colon | 2 | 1991 | 1797 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 2 | 2 | 2008 | 313 | 0.090 |
Why?
|
| Zinc | 3 | 1984 | 675 | 0.090 |
Why?
|
| Fushi Tarazu Transcription Factors | 2 | 2000 | 24 | 0.090 |
Why?
|
| Phosphorylation | 15 | 2012 | 8310 | 0.090 |
Why?
|
| Genes | 4 | 1998 | 1824 | 0.090 |
Why?
|
| Steroidogenic Factor 1 | 2 | 2000 | 45 | 0.090 |
Why?
|
| Recreation | 1 | 1990 | 124 | 0.080 |
Why?
|
| DNA Primers | 5 | 2010 | 2827 | 0.080 |
Why?
|
| Protein Binding | 2 | 2025 | 9327 | 0.080 |
Why?
|
| Immunohistochemistry | 11 | 2012 | 11063 | 0.080 |
Why?
|
| Estrus | 1 | 1989 | 70 | 0.080 |
Why?
|
| Disease Models, Animal | 6 | 2023 | 18330 | 0.080 |
Why?
|
| Cesarean Section | 1 | 2018 | 1419 | 0.080 |
Why?
|
| Carcinoma, Squamous Cell | 4 | 2012 | 4049 | 0.080 |
Why?
|
| Activins | 3 | 2021 | 211 | 0.080 |
Why?
|
| Skin Transplantation | 3 | 1992 | 1097 | 0.080 |
Why?
|
| Drug Resistance, Neoplasm | 3 | 2016 | 5332 | 0.080 |
Why?
|
| Rectum | 5 | 1991 | 898 | 0.080 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2017 | 2887 | 0.080 |
Why?
|
| Hypoglossal Nerve | 1 | 2010 | 110 | 0.080 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2013 | 832 | 0.080 |
Why?
|
| Up-Regulation | 3 | 2016 | 4143 | 0.080 |
Why?
|
| Cytological Techniques | 1 | 1991 | 217 | 0.080 |
Why?
|
| Estradiol | 5 | 2020 | 1951 | 0.080 |
Why?
|
| Tumor Burden | 1 | 2015 | 1903 | 0.080 |
Why?
|
| Leiomyomatosis | 1 | 2009 | 69 | 0.080 |
Why?
|
| Graft vs Host Reaction | 2 | 1986 | 99 | 0.080 |
Why?
|
| Stainless Steel | 1 | 1989 | 79 | 0.080 |
Why?
|
| Fibroblasts | 3 | 2016 | 4167 | 0.080 |
Why?
|
| Algorithms | 2 | 2011 | 14098 | 0.080 |
Why?
|
| Chorionic Gonadotropin | 2 | 2007 | 458 | 0.080 |
Why?
|
| Stromal Cells | 2 | 2012 | 1335 | 0.080 |
Why?
|
| Progesterone | 5 | 2020 | 752 | 0.080 |
Why?
|
| Wolffian Ducts | 1 | 2008 | 27 | 0.080 |
Why?
|
| Steroids | 3 | 2004 | 937 | 0.080 |
Why?
|
| Models, Molecular | 5 | 2025 | 5388 | 0.080 |
Why?
|
| Fibrosarcoma | 1 | 2010 | 313 | 0.080 |
Why?
|
| Chromones | 1 | 2008 | 148 | 0.080 |
Why?
|
| Gastrula | 2 | 1999 | 83 | 0.080 |
Why?
|
| Bone Morphogenetic Proteins | 3 | 2021 | 845 | 0.080 |
Why?
|
| Uniparental Disomy | 1 | 2008 | 46 | 0.080 |
Why?
|
| RNA, Small Interfering | 4 | 2017 | 3427 | 0.080 |
Why?
|
| Cryosurgery | 2 | 1984 | 479 | 0.080 |
Why?
|
| Endotoxins | 1 | 1990 | 519 | 0.080 |
Why?
|
| Exons | 3 | 2016 | 2391 | 0.080 |
Why?
|
| Rectovaginal Fistula | 1 | 1988 | 12 | 0.080 |
Why?
|
| Vas Deferens | 1 | 1988 | 55 | 0.080 |
Why?
|
| Tracheoesophageal Fistula | 2 | 2005 | 131 | 0.080 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2013 | 3797 | 0.070 |
Why?
|
| Carrier Proteins | 3 | 1996 | 4925 | 0.070 |
Why?
|
| Herbicides | 2 | 2007 | 104 | 0.070 |
Why?
|
| Biological Assay | 6 | 1992 | 626 | 0.070 |
Why?
|
| Seminal Vesicles | 1 | 1988 | 101 | 0.070 |
Why?
|
| Hematometra | 1 | 1987 | 3 | 0.070 |
Why?
|
| Hematocolpos | 1 | 1987 | 5 | 0.070 |
Why?
|
| Chromosome Deletion | 3 | 2012 | 1384 | 0.070 |
Why?
|
| GTP-Binding Protein gamma Subunits | 1 | 2007 | 22 | 0.070 |
Why?
|
| Surgical Flaps | 2 | 1996 | 1680 | 0.070 |
Why?
|
| Sex-Determining Region Y Protein | 5 | 2001 | 15 | 0.070 |
Why?
|
| Clone Cells | 1 | 1991 | 1669 | 0.070 |
Why?
|
| Anus, Imperforate | 1 | 1988 | 63 | 0.070 |
Why?
|
| Lasers | 1 | 2012 | 951 | 0.070 |
Why?
|
| Molecular Biology | 2 | 2008 | 573 | 0.070 |
Why?
|
| Sequence Analysis, DNA | 2 | 2014 | 4780 | 0.070 |
Why?
|
| Adult | 32 | 2023 | 223317 | 0.070 |
Why?
|
| Mice, Transgenic | 6 | 2023 | 9551 | 0.070 |
Why?
|
| Mutagenesis, Site-Directed | 4 | 2020 | 1677 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 6 | 2010 | 10748 | 0.070 |
Why?
|
| Mitogen-Activated Protein Kinases | 3 | 2002 | 1244 | 0.070 |
Why?
|
| Mice, SCID | 5 | 2016 | 2626 | 0.070 |
Why?
|
| Rectal Fistula | 1 | 1988 | 76 | 0.070 |
Why?
|
| Intestinal Diseases | 1 | 1992 | 505 | 0.070 |
Why?
|
| Binding Sites | 4 | 2016 | 6014 | 0.070 |
Why?
|
| Activin Receptors | 3 | 2000 | 40 | 0.070 |
Why?
|
| Mitosis | 1 | 1992 | 1176 | 0.070 |
Why?
|
| Alternative Splicing | 2 | 2016 | 1103 | 0.070 |
Why?
|
| Receptors, Cell Surface | 3 | 1993 | 2815 | 0.070 |
Why?
|
| Pelvis | 2 | 2022 | 736 | 0.070 |
Why?
|
| Proteolipids | 2 | 1999 | 109 | 0.070 |
Why?
|
| Parasympathetic Nervous System | 2 | 1985 | 144 | 0.070 |
Why?
|
| Contraception | 2 | 2023 | 362 | 0.070 |
Why?
|
| Nitriles | 2 | 2022 | 980 | 0.070 |
Why?
|
| Tuberculosis, Urogenital | 1 | 1986 | 9 | 0.070 |
Why?
|
| Embryonic Structures | 1 | 2006 | 10 | 0.070 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2013 | 1655 | 0.070 |
Why?
|
| DNA Mutational Analysis | 4 | 2016 | 4114 | 0.070 |
Why?
|
| Cloning, Molecular | 4 | 1999 | 4167 | 0.070 |
Why?
|
| Guanidines | 1 | 2007 | 194 | 0.070 |
Why?
|
| Mitogen-Activated Protein Kinase 6 | 1 | 2005 | 11 | 0.070 |
Why?
|
| Premature Birth | 1 | 2018 | 1830 | 0.070 |
Why?
|
| Environment | 1 | 2012 | 1120 | 0.070 |
Why?
|
| Major Histocompatibility Complex | 1 | 1989 | 879 | 0.070 |
Why?
|
| GATA4 Transcription Factor | 2 | 2012 | 125 | 0.060 |
Why?
|
| Sexual Behavior, Animal | 1 | 2007 | 120 | 0.060 |
Why?
|
| Verapamil | 1 | 2006 | 242 | 0.060 |
Why?
|
| Tumor Stem Cell Assay | 1 | 1985 | 116 | 0.060 |
Why?
|
| Neoplasm Invasiveness | 2 | 2012 | 3611 | 0.060 |
Why?
|
| Melanoma | 3 | 1995 | 5702 | 0.060 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2007 | 440 | 0.060 |
Why?
|
| Lung Neoplasms | 4 | 2016 | 13491 | 0.060 |
Why?
|
| Alleles | 2 | 2016 | 6893 | 0.060 |
Why?
|
| Lordosis | 1 | 2007 | 100 | 0.060 |
Why?
|
| Ovum | 1 | 2006 | 187 | 0.060 |
Why?
|
| Kidney Transplantation | 4 | 1989 | 4268 | 0.060 |
Why?
|
| Laminin | 2 | 1984 | 404 | 0.060 |
Why?
|
| Paclitaxel | 2 | 2010 | 1728 | 0.060 |
Why?
|
| Membrane Proteins | 7 | 2018 | 7868 | 0.060 |
Why?
|
| Pyridazines | 1 | 2007 | 199 | 0.060 |
Why?
|
| Morpholines | 1 | 2008 | 584 | 0.060 |
Why?
|
| Time Factors | 15 | 2013 | 40154 | 0.060 |
Why?
|
| Teratocarcinoma | 1 | 2005 | 16 | 0.060 |
Why?
|
| Chemokines, CXC | 1 | 2007 | 420 | 0.060 |
Why?
|
| Colony-Forming Units Assay | 1 | 1985 | 351 | 0.060 |
Why?
|
| Gene Expression Profiling | 5 | 2019 | 9532 | 0.060 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 2 | 2000 | 857 | 0.060 |
Why?
|
| Genome, Human | 3 | 2008 | 4441 | 0.060 |
Why?
|
| Gastroesophageal Reflux | 2 | 2004 | 834 | 0.060 |
Why?
|
| Protein-Tyrosine Kinases | 6 | 2002 | 2428 | 0.060 |
Why?
|
| Microtubule Proteins | 1 | 2004 | 61 | 0.060 |
Why?
|
| Neoplasm Proteins | 3 | 2002 | 3599 | 0.060 |
Why?
|
| Smith-Lemli-Opitz Syndrome | 1 | 2004 | 46 | 0.060 |
Why?
|
| Histocytochemistry | 6 | 1986 | 697 | 0.060 |
Why?
|
| Respiratory System | 1 | 2008 | 563 | 0.060 |
Why?
|
| Tretinoin | 1 | 2007 | 524 | 0.060 |
Why?
|
| Histocompatibility Antigens Class I | 4 | 1992 | 1362 | 0.060 |
Why?
|
| Glycogen | 2 | 1996 | 252 | 0.060 |
Why?
|
| Immunophilins | 1 | 2004 | 20 | 0.060 |
Why?
|
| Neoplasms, Experimental | 3 | 2001 | 1228 | 0.060 |
Why?
|
| Rosaniline Dyes | 1 | 1984 | 50 | 0.060 |
Why?
|
| Staining and Labeling | 5 | 1995 | 1076 | 0.060 |
Why?
|
| Antibody Formation | 2 | 1990 | 1392 | 0.060 |
Why?
|
| Laryngostenosis | 2 | 1984 | 168 | 0.060 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2005 | 478 | 0.060 |
Why?
|
| Cohort Studies | 3 | 2021 | 41718 | 0.060 |
Why?
|
| Lung Compliance | 4 | 1997 | 207 | 0.060 |
Why?
|
| Endometriosis | 1 | 2012 | 873 | 0.060 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2008 | 606 | 0.060 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2004 | 4572 | 0.060 |
Why?
|
| Wnt Proteins | 1 | 2008 | 723 | 0.060 |
Why?
|
| Protein Processing, Post-Translational | 1 | 1991 | 1965 | 0.050 |
Why?
|
| Cell Cycle Proteins | 2 | 2006 | 3440 | 0.050 |
Why?
|
| Population Control | 1 | 2023 | 23 | 0.050 |
Why?
|
| Antibodies, Monoclonal | 8 | 1992 | 9245 | 0.050 |
Why?
|
| Mesenchymal Stem Cells | 2 | 2016 | 1665 | 0.050 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2012 | 1536 | 0.050 |
Why?
|
| Subrenal Capsule Assay | 3 | 1992 | 27 | 0.050 |
Why?
|
| Sterilization, Reproductive | 1 | 2023 | 24 | 0.050 |
Why?
|
| Animals, Wild | 1 | 2023 | 78 | 0.050 |
Why?
|
| Conserved Sequence | 1 | 2006 | 1160 | 0.050 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 2 | 2003 | 705 | 0.050 |
Why?
|
| Complement C3 | 1 | 2005 | 434 | 0.050 |
Why?
|
| Sequence Homology, Nucleic Acid | 3 | 2000 | 1057 | 0.050 |
Why?
|
| Adipogenesis | 1 | 2005 | 370 | 0.050 |
Why?
|
| Chickens | 3 | 2016 | 843 | 0.050 |
Why?
|
| Green Fluorescent Proteins | 1 | 2008 | 2063 | 0.050 |
Why?
|
| 1-Methyl-3-isobutylxanthine | 3 | 1988 | 100 | 0.050 |
Why?
|
| Luciferases | 2 | 2006 | 713 | 0.050 |
Why?
|
| Enzyme Activation | 1 | 2008 | 3587 | 0.050 |
Why?
|
| Axons | 1 | 2010 | 1675 | 0.050 |
Why?
|
| Macrolides | 1 | 2004 | 204 | 0.050 |
Why?
|
| Diethylstilbestrol | 1 | 1982 | 85 | 0.050 |
Why?
|
| Genes, Homeobox | 1 | 2004 | 289 | 0.050 |
Why?
|
| Cholangitis | 1 | 1983 | 110 | 0.050 |
Why?
|
| Models, Biological | 7 | 2012 | 9464 | 0.050 |
Why?
|
| Golgi Apparatus | 1 | 1984 | 406 | 0.050 |
Why?
|
| Breast Neoplasms | 5 | 2010 | 21178 | 0.050 |
Why?
|
| Cell Line, Transformed | 1 | 2003 | 861 | 0.050 |
Why?
|
| Collagen | 3 | 1989 | 2636 | 0.050 |
Why?
|
| Spermatozoa | 1 | 2006 | 625 | 0.050 |
Why?
|
| Organ Size | 6 | 2003 | 2264 | 0.050 |
Why?
|
| Blood Vessels | 1 | 2008 | 1110 | 0.050 |
Why?
|
| Antibody Specificity | 4 | 1992 | 1062 | 0.050 |
Why?
|
| Diagnosis, Differential | 6 | 2004 | 12986 | 0.050 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2005 | 496 | 0.050 |
Why?
|
| Butadienes | 1 | 2002 | 107 | 0.050 |
Why?
|
| Safety Management | 1 | 2008 | 765 | 0.050 |
Why?
|
| Sequence Analysis, RNA | 2 | 2021 | 2040 | 0.050 |
Why?
|
| Cats | 1 | 2023 | 972 | 0.050 |
Why?
|
| Smad6 Protein | 1 | 2001 | 14 | 0.050 |
Why?
|
| Constipation | 2 | 1986 | 570 | 0.050 |
Why?
|
| Phylogeny | 2 | 2006 | 2840 | 0.050 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2005 | 694 | 0.050 |
Why?
|
| Interprofessional Relations | 1 | 2008 | 1000 | 0.050 |
Why?
|
| Structural Homology, Protein | 1 | 2021 | 86 | 0.050 |
Why?
|
| Cell Membrane | 7 | 1996 | 3642 | 0.050 |
Why?
|
| Head and Neck Neoplasms | 2 | 2010 | 2930 | 0.050 |
Why?
|
| Antigens | 2 | 2005 | 1442 | 0.050 |
Why?
|
| Jejunum | 1 | 1983 | 474 | 0.050 |
Why?
|
| Radioimmunoassay | 4 | 1986 | 861 | 0.050 |
Why?
|
| Rubidium | 1 | 2000 | 120 | 0.050 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2025 | 678 | 0.050 |
Why?
|
| Benzimidazoles | 1 | 2006 | 862 | 0.050 |
Why?
|
| Culture Techniques | 4 | 2002 | 529 | 0.050 |
Why?
|
| Mice, Nude | 5 | 2006 | 3618 | 0.050 |
Why?
|
| Cell Cycle | 5 | 2012 | 2927 | 0.050 |
Why?
|
| Kidney | 8 | 2007 | 7063 | 0.050 |
Why?
|
| Adolescent | 22 | 2005 | 89046 | 0.050 |
Why?
|
| Heart | 2 | 2012 | 4429 | 0.040 |
Why?
|
| Proteoglycans | 1 | 1984 | 807 | 0.040 |
Why?
|
| TATA Box | 1 | 2000 | 127 | 0.040 |
Why?
|
| Genetic Counseling | 1 | 2004 | 635 | 0.040 |
Why?
|
| Diagnosis | 1 | 2001 | 157 | 0.040 |
Why?
|
| Laryngeal Neoplasms | 1 | 1984 | 514 | 0.040 |
Why?
|
| Electrophoresis | 1 | 2000 | 226 | 0.040 |
Why?
|
| Cryoelectron Microscopy | 1 | 2025 | 645 | 0.040 |
Why?
|
| Adaptor Proteins, Signal Transducing | 3 | 2017 | 2902 | 0.040 |
Why?
|
| Thiazoles | 2 | 2022 | 1530 | 0.040 |
Why?
|
| Drug Evaluation, Preclinical | 2 | 2022 | 1331 | 0.040 |
Why?
|
| Sequence Alignment | 3 | 2004 | 2176 | 0.040 |
Why?
|
| G1 Phase | 2 | 2012 | 403 | 0.040 |
Why?
|
| Adrenal Glands | 2 | 1997 | 557 | 0.040 |
Why?
|
| Software | 2 | 2011 | 4472 | 0.040 |
Why?
|
| Sheep | 3 | 1999 | 1449 | 0.040 |
Why?
|
| Fetal Development | 1 | 2005 | 777 | 0.040 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2003 | 661 | 0.040 |
Why?
|
| Retinoblastoma Protein | 1 | 2003 | 670 | 0.040 |
Why?
|
| DNA Footprinting | 1 | 2000 | 97 | 0.040 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2002 | 482 | 0.040 |
Why?
|
| Liver Transplantation | 3 | 1987 | 2416 | 0.040 |
Why?
|
| Immediate-Early Proteins | 4 | 2007 | 444 | 0.040 |
Why?
|
| Calcium Channels | 1 | 2004 | 622 | 0.040 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 6 | 1996 | 3804 | 0.040 |
Why?
|
| Estrogens | 4 | 1991 | 1536 | 0.040 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2002 | 501 | 0.040 |
Why?
|
| MicroRNAs | 1 | 2016 | 3792 | 0.040 |
Why?
|
| Cervix Uteri | 1 | 2003 | 575 | 0.040 |
Why?
|
| Abdominal Muscles | 1 | 1980 | 172 | 0.040 |
Why?
|
| Parenteral Nutrition, Total | 1 | 1980 | 304 | 0.040 |
Why?
|
| Activin Receptors, Type II | 1 | 2020 | 122 | 0.040 |
Why?
|
| Protein Multimerization | 1 | 2025 | 961 | 0.040 |
Why?
|
| Fluorescent Dyes | 2 | 2006 | 1928 | 0.040 |
Why?
|
| Gender Identity | 2 | 2003 | 769 | 0.040 |
Why?
|
| Corpus Luteum | 2 | 1992 | 81 | 0.040 |
Why?
|
| Case-Control Studies | 3 | 2024 | 22254 | 0.040 |
Why?
|
| Cystadenoma | 1 | 1979 | 76 | 0.040 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2005 | 584 | 0.040 |
Why?
|
| Cell Survival | 7 | 2012 | 5750 | 0.040 |
Why?
|
| Central Nervous System | 1 | 2007 | 1345 | 0.040 |
Why?
|
| Mice, Inbred Strains | 3 | 2003 | 1765 | 0.040 |
Why?
|
| Hernia, Hiatal | 1 | 1980 | 90 | 0.040 |
Why?
|
| Calmodulin-Binding Proteins | 2 | 2000 | 238 | 0.040 |
Why?
|
| Oocyte Retrieval | 1 | 2020 | 162 | 0.040 |
Why?
|
| Neoplasm Transplantation | 4 | 2002 | 2012 | 0.040 |
Why?
|
| Hemangioma | 1 | 1984 | 727 | 0.040 |
Why?
|
| Branchioma | 1 | 1979 | 17 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2002 | 635 | 0.040 |
Why?
|
| Papillomavirus Infections | 1 | 2011 | 1639 | 0.040 |
Why?
|
| Cyclosporine | 2 | 1992 | 778 | 0.040 |
Why?
|
| Cell Transplantation | 1 | 2001 | 475 | 0.040 |
Why?
|
| Uterine Inertia | 1 | 2018 | 29 | 0.040 |
Why?
|
| Clitoris | 3 | 2003 | 35 | 0.040 |
Why?
|
| Proteome | 1 | 2008 | 1890 | 0.040 |
Why?
|
| Indicator Dilution Techniques | 1 | 2018 | 43 | 0.040 |
Why?
|
| Surgery, Plastic | 3 | 1984 | 652 | 0.040 |
Why?
|
| Edetic Acid | 3 | 1984 | 277 | 0.040 |
Why?
|
| Escherichia coli | 1 | 1990 | 4209 | 0.040 |
Why?
|
| Isotopes | 1 | 2018 | 125 | 0.040 |
Why?
|
| Endoplasmic Reticulum | 1 | 1984 | 1132 | 0.040 |
Why?
|
| Binding Sites, Antibody | 2 | 1992 | 340 | 0.040 |
Why?
|
| Tacrolimus Binding Proteins | 2 | 1996 | 199 | 0.040 |
Why?
|
| Dog Diseases | 2 | 1989 | 143 | 0.040 |
Why?
|
| Gene Deletion | 1 | 2005 | 2668 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 4 | 2012 | 6067 | 0.040 |
Why?
|
| Evolution, Molecular | 1 | 2006 | 1893 | 0.040 |
Why?
|
| Caseins | 1 | 2018 | 105 | 0.040 |
Why?
|
| Sex Chromosomes | 1 | 1978 | 101 | 0.040 |
Why?
|
| Microscopy, Electron | 4 | 1991 | 2551 | 0.040 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1999 | 492 | 0.040 |
Why?
|
| RNA Interference | 2 | 2017 | 2829 | 0.040 |
Why?
|
| Adenocarcinoma | 3 | 2012 | 6360 | 0.040 |
Why?
|
| Aged, 80 and over | 4 | 2016 | 59548 | 0.040 |
Why?
|
| Wounds and Injuries | 1 | 1990 | 2513 | 0.040 |
Why?
|
| Glutathione Reductase | 1 | 1997 | 25 | 0.040 |
Why?
|
| Cell Death | 2 | 2010 | 1677 | 0.040 |
Why?
|
| Prognosis | 4 | 2020 | 29963 | 0.040 |
Why?
|
| Pregnancy Rate | 1 | 2020 | 655 | 0.040 |
Why?
|
| Labor, Obstetric | 1 | 1980 | 313 | 0.040 |
Why?
|
| Salivary Glands | 1 | 1979 | 231 | 0.040 |
Why?
|
| High Mobility Group Proteins | 1 | 1998 | 179 | 0.040 |
Why?
|
| Kinetics | 5 | 2002 | 6287 | 0.040 |
Why?
|
| Choristoma | 1 | 1979 | 205 | 0.030 |
Why?
|
| Tissue Preservation | 1 | 1977 | 170 | 0.030 |
Why?
|
| In Situ Hybridization, Fluorescence | 3 | 2010 | 2509 | 0.030 |
Why?
|
| Prevalence | 1 | 2014 | 15851 | 0.030 |
Why?
|
| Protein Structure, Tertiary | 1 | 2004 | 3760 | 0.030 |
Why?
|
| Myristic Acid | 1 | 1996 | 49 | 0.030 |
Why?
|
| Myristic Acids | 1 | 1996 | 49 | 0.030 |
Why?
|
| Education, Medical, Graduate | 2 | 2008 | 2420 | 0.030 |
Why?
|
| S Phase | 2 | 2011 | 424 | 0.030 |
Why?
|
| Crystallography, X-Ray | 1 | 2021 | 1947 | 0.030 |
Why?
|
| Culture Media | 2 | 1991 | 892 | 0.030 |
Why?
|
| Octoxynol | 2 | 1988 | 76 | 0.030 |
Why?
|
| Common Bile Duct | 1 | 1976 | 106 | 0.030 |
Why?
|
| Primary Ovarian Insufficiency | 1 | 2017 | 108 | 0.030 |
Why?
|
| DNA, Complementary | 1 | 1999 | 1989 | 0.030 |
Why?
|
| Phosphoprotein Phosphatases | 2 | 1996 | 327 | 0.030 |
Why?
|
| Mosaicism | 3 | 2010 | 480 | 0.030 |
Why?
|
| Multifactorial Inheritance | 1 | 2024 | 1422 | 0.030 |
Why?
|
| Actins | 1 | 2023 | 2059 | 0.030 |
Why?
|
| Bone Morphogenetic Protein Receptors, Type II | 1 | 2016 | 72 | 0.030 |
Why?
|
| Glutathione Peroxidase | 1 | 1997 | 259 | 0.030 |
Why?
|
| Brain Neoplasms | 1 | 1997 | 9108 | 0.030 |
Why?
|
| Parenteral Nutrition | 1 | 1980 | 663 | 0.030 |
Why?
|
| Carcinoma | 2 | 1985 | 2326 | 0.030 |
Why?
|
| Ampulla of Vater | 1 | 1976 | 150 | 0.030 |
Why?
|
| Puberty, Precocious | 1 | 1997 | 166 | 0.030 |
Why?
|
| Calibration | 1 | 2018 | 817 | 0.030 |
Why?
|
| Enzyme Inhibitors | 2 | 2007 | 3726 | 0.030 |
Why?
|
| Bucladesine | 2 | 1986 | 118 | 0.030 |
Why?
|
| Biliary Tract Diseases | 1 | 1976 | 159 | 0.030 |
Why?
|
| Transplantation, Homologous | 3 | 1991 | 4838 | 0.030 |
Why?
|
| Adenoviridae | 1 | 2000 | 1092 | 0.030 |
Why?
|
| Interferon Regulatory Factor-1 | 2 | 2007 | 69 | 0.030 |
Why?
|
| Apoptotic Protease-Activating Factor 1 | 1 | 2015 | 21 | 0.030 |
Why?
|
| DNA Repair | 1 | 2025 | 2050 | 0.030 |
Why?
|
| Ligands | 3 | 2000 | 3273 | 0.030 |
Why?
|
| Calcineurin | 1 | 1996 | 235 | 0.030 |
Why?
|
| Protein Tyrosine Phosphatases | 2 | 1996 | 457 | 0.030 |
Why?
|
| Middle Aged | 10 | 2020 | 223233 | 0.030 |
Why?
|
| Interferon-gamma | 1 | 2003 | 3154 | 0.030 |
Why?
|
| Mineralocorticoids | 1 | 1995 | 37 | 0.030 |
Why?
|
| Binding, Competitive | 2 | 1994 | 1141 | 0.030 |
Why?
|
| Blastocyst | 1 | 1998 | 432 | 0.030 |
Why?
|
| Databases, Genetic | 2 | 2012 | 1758 | 0.030 |
Why?
|
| Pulmonary Surfactant-Associated Proteins | 1 | 1994 | 18 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase 2 | 1 | 2015 | 185 | 0.030 |
Why?
|
| Forecasting | 1 | 2004 | 2936 | 0.030 |
Why?
|
| Mammals | 2 | 1998 | 1135 | 0.030 |
Why?
|
| Superoxide Dismutase | 1 | 1997 | 596 | 0.030 |
Why?
|
| Fertility | 1 | 2019 | 771 | 0.030 |
Why?
|
| Hybridomas | 4 | 1984 | 442 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 1991 | 8940 | 0.030 |
Why?
|
| Fludrocortisone | 1 | 1994 | 24 | 0.030 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2025 | 2952 | 0.030 |
Why?
|
| Injections, Intravenous | 1 | 1996 | 1377 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 2015 | 287 | 0.030 |
Why?
|
| Molecular Probes | 1 | 1996 | 309 | 0.030 |
Why?
|
| Aged | 7 | 2016 | 171319 | 0.030 |
Why?
|
| Second Messenger Systems | 1 | 1994 | 203 | 0.030 |
Why?
|
| Transcriptional Activation | 1 | 2000 | 1751 | 0.030 |
Why?
|
| Integrases | 2 | 2007 | 520 | 0.030 |
Why?
|
| Attitude of Health Personnel | 1 | 2008 | 3928 | 0.030 |
Why?
|
| Amino Acid Oxidoreductases | 1 | 1994 | 149 | 0.030 |
Why?
|
| 3' Untranslated Regions | 1 | 2016 | 515 | 0.030 |
Why?
|
| Medroxyprogesterone | 2 | 1984 | 34 | 0.030 |
Why?
|
| Respiratory Mechanics | 2 | 1995 | 720 | 0.030 |
Why?
|
| Prostate | 1 | 2002 | 1761 | 0.030 |
Why?
|
| Cortisone | 1 | 1994 | 90 | 0.030 |
Why?
|
| Lung Volume Measurements | 1 | 1994 | 381 | 0.030 |
Why?
|
| 17-alpha-Hydroxyprogesterone | 2 | 2004 | 22 | 0.030 |
Why?
|
| Leydig Cell Tumor | 2 | 2003 | 28 | 0.030 |
Why?
|
| Pneumothorax | 2 | 1997 | 393 | 0.030 |
Why?
|
| In Situ Nick-End Labeling | 2 | 2005 | 610 | 0.030 |
Why?
|
| Antigens, Differentiation, B-Lymphocyte | 1 | 2013 | 318 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2008 | 8068 | 0.030 |
Why?
|
| Drug Synergism | 3 | 2003 | 1759 | 0.030 |
Why?
|
| SOXF Transcription Factors | 1 | 2012 | 31 | 0.030 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 1 | 1995 | 239 | 0.030 |
Why?
|
| Longitudinal Studies | 2 | 2020 | 14766 | 0.030 |
Why?
|
| Sphingolipids | 1 | 1994 | 177 | 0.030 |
Why?
|
| Organ Specificity | 2 | 2008 | 1966 | 0.030 |
Why?
|
| Immunoglobulin Idiotypes | 1 | 1992 | 200 | 0.030 |
Why?
|
| Neovascularization, Physiologic | 1 | 2000 | 1368 | 0.030 |
Why?
|
| Membrane Glycoproteins | 4 | 2002 | 3702 | 0.030 |
Why?
|
| Tetrazolium Salts | 1 | 2012 | 92 | 0.030 |
Why?
|
| Pneumoperitoneum | 1 | 1972 | 46 | 0.030 |
Why?
|
| DNA-(Apurinic or Apyrimidinic Site) Lyase | 1 | 2012 | 72 | 0.030 |
Why?
|
| Corticosterone | 2 | 1984 | 301 | 0.030 |
Why?
|
| Aromatase | 1 | 1993 | 147 | 0.030 |
Why?
|
| Infant, Premature, Diseases | 2 | 1982 | 712 | 0.030 |
Why?
|
| Immunosorbent Techniques | 1 | 1992 | 174 | 0.030 |
Why?
|
| Sexual Maturation | 2 | 1989 | 258 | 0.030 |
Why?
|
| Annexin A5 | 1 | 2012 | 102 | 0.020 |
Why?
|
| Epithelium | 4 | 1992 | 1606 | 0.020 |
Why?
|
| Collateral Circulation | 1 | 1973 | 289 | 0.020 |
Why?
|
| Renal Artery Obstruction | 1 | 1973 | 216 | 0.020 |
Why?
|
| Breast | 1 | 2001 | 1972 | 0.020 |
Why?
|
| Osmolar Concentration | 2 | 1994 | 654 | 0.020 |
Why?
|
| Maternal-Fetal Exchange | 1 | 1994 | 454 | 0.020 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 1992 | 220 | 0.020 |
Why?
|
| Oncogene Proteins | 1 | 2016 | 715 | 0.020 |
Why?
|
| Poly A | 1 | 1992 | 180 | 0.020 |
Why?
|
| E2F Transcription Factors | 1 | 2012 | 270 | 0.020 |
Why?
|
| DNA Glycosylases | 1 | 2012 | 125 | 0.020 |
Why?
|
| Urography | 3 | 1983 | 316 | 0.020 |
Why?
|
| Urogenital Neoplasms | 1 | 1993 | 130 | 0.020 |
Why?
|
| Fetal Tissue Transplantation | 1 | 1992 | 139 | 0.020 |
Why?
|
| Apoptosis Regulatory Proteins | 3 | 2002 | 1150 | 0.020 |
Why?
|
| Cell Count | 3 | 2003 | 1825 | 0.020 |
Why?
|
| Hearing Loss, Sensorineural | 2 | 2008 | 783 | 0.020 |
Why?
|
| Zinc Fingers | 1 | 1994 | 577 | 0.020 |
Why?
|
| Mice, Inbred C3H | 2 | 2003 | 915 | 0.020 |
Why?
|
| Pyrazoles | 1 | 2022 | 2028 | 0.020 |
Why?
|
| Bronchi | 3 | 2005 | 847 | 0.020 |
Why?
|
| Sex Factors | 5 | 2007 | 10622 | 0.020 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2016 | 754 | 0.020 |
Why?
|
| Dialysis | 1 | 1991 | 72 | 0.020 |
Why?
|
| Arginine | 1 | 1995 | 931 | 0.020 |
Why?
|
| Chromatography | 1 | 1991 | 189 | 0.020 |
Why?
|
| Hernia, Inguinal | 2 | 2008 | 224 | 0.020 |
Why?
|
| Computer Peripherals | 1 | 1991 | 38 | 0.020 |
Why?
|
| Nitric Oxide Synthase | 1 | 1994 | 911 | 0.020 |
Why?
|
| Serine | 1 | 1995 | 828 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2020 | 4280 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 2012 | 451 | 0.020 |
Why?
|
| Acid-Base Equilibrium | 1 | 1971 | 180 | 0.020 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 1994 | 506 | 0.020 |
Why?
|
| Risk Factors | 3 | 2024 | 74886 | 0.020 |
Why?
|
| Genes, p16 | 1 | 2011 | 158 | 0.020 |
Why?
|
| Age Factors | 6 | 2003 | 18401 | 0.020 |
Why?
|
| Reference Values | 4 | 2003 | 4918 | 0.020 |
Why?
|
| Hypophysectomy | 2 | 2003 | 114 | 0.020 |
Why?
|
| Flow Cytometry | 2 | 2009 | 5891 | 0.020 |
Why?
|
| Polyethylene Glycols | 2 | 1988 | 1188 | 0.020 |
Why?
|
| Women's Health | 1 | 2020 | 2082 | 0.020 |
Why?
|
| Urethra | 1 | 1992 | 406 | 0.020 |
Why?
|
| Depression, Chemical | 1 | 1990 | 186 | 0.020 |
Why?
|
| Crosses, Genetic | 1 | 1991 | 751 | 0.020 |
Why?
|
| Urogenital System | 2 | 1997 | 88 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 1992 | 2478 | 0.020 |
Why?
|
| Tumor Microenvironment | 1 | 2023 | 3944 | 0.020 |
Why?
|
| Lymphocyte Subsets | 1 | 1991 | 313 | 0.020 |
Why?
|
| Protein Conformation | 1 | 1998 | 3948 | 0.020 |
Why?
|
| Developmental Disabilities | 1 | 2018 | 1518 | 0.020 |
Why?
|
| Multigene Family | 1 | 1993 | 1081 | 0.020 |
Why?
|
| Pyrimidines | 1 | 2022 | 3044 | 0.020 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2010 | 11872 | 0.020 |
Why?
|
| Single-Cell Analysis | 1 | 2021 | 2538 | 0.020 |
Why?
|
| Biopsy | 3 | 2003 | 6777 | 0.020 |
Why?
|
| Genotype | 2 | 2016 | 13035 | 0.020 |
Why?
|
| Adipocytes | 2 | 2007 | 1197 | 0.020 |
Why?
|
| Brain Chemistry | 1 | 1993 | 951 | 0.020 |
Why?
|
| Human papillomavirus 16 | 1 | 2011 | 268 | 0.020 |
Why?
|
| Heart Defects, Congenital | 2 | 2018 | 4713 | 0.020 |
Why?
|
| Transforming Growth Factors | 1 | 1988 | 76 | 0.020 |
Why?
|
| Ovariectomy | 1 | 1991 | 612 | 0.020 |
Why?
|
| Iodine Radioisotopes | 1 | 1992 | 1029 | 0.020 |
Why?
|
| Biomedical Research | 1 | 2004 | 3464 | 0.020 |
Why?
|
| Esophageal Atresia | 1 | 1972 | 226 | 0.020 |
Why?
|
| Drosophila | 1 | 1996 | 1509 | 0.020 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 1991 | 719 | 0.020 |
Why?
|
| PubMed | 1 | 2008 | 129 | 0.020 |
Why?
|
| Genes, Lethal | 2 | 1999 | 224 | 0.020 |
Why?
|
| Detergents | 1 | 1988 | 235 | 0.020 |
Why?
|
| Gene Library | 1 | 1991 | 1065 | 0.020 |
Why?
|
| Androstenedione | 2 | 2004 | 132 | 0.020 |
Why?
|
| Gynecology | 1 | 1994 | 534 | 0.020 |
Why?
|
| Inguinal Canal | 1 | 1967 | 71 | 0.020 |
Why?
|
| Manometry | 3 | 1986 | 458 | 0.020 |
Why?
|
| Tracheotomy | 2 | 1982 | 174 | 0.020 |
Why?
|
| Chemokine CXCL2 | 1 | 2007 | 105 | 0.020 |
Why?
|
| Encephalocele | 1 | 2008 | 135 | 0.020 |
Why?
|
| Pituitary Gland | 2 | 1983 | 635 | 0.020 |
Why?
|
| Drug Resistance | 1 | 1993 | 1592 | 0.020 |
Why?
|
| Neovascularization, Pathologic | 2 | 2009 | 2627 | 0.020 |
Why?
|
| United States | 3 | 2020 | 72971 | 0.020 |
Why?
|
| Cadherins | 1 | 2012 | 903 | 0.020 |
Why?
|
| Body Weight | 3 | 1996 | 4627 | 0.020 |
Why?
|
| Biliary Atresia | 1 | 1987 | 88 | 0.020 |
Why?
|
| Glucocorticoids | 2 | 1995 | 2163 | 0.020 |
Why?
|
| Radiography | 4 | 1996 | 6975 | 0.020 |
Why?
|
| Stomach | 2 | 2005 | 701 | 0.020 |
Why?
|
| Tuberculosis, Renal | 1 | 1986 | 2 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2012 | 2850 | 0.020 |
Why?
|
| Phonocardiography | 1 | 1966 | 30 | 0.020 |
Why?
|
| Survival Analysis | 2 | 2016 | 10092 | 0.020 |
Why?
|
| Nails, Malformed | 1 | 2006 | 34 | 0.020 |
Why?
|
| Ureteral Diseases | 1 | 1986 | 63 | 0.020 |
Why?
|
| Eye Diseases, Hereditary | 1 | 2007 | 124 | 0.020 |
Why?
|
| Microchemistry | 1 | 1986 | 54 | 0.020 |
Why?
|
| Altretamine | 1 | 1985 | 11 | 0.020 |
Why?
|
| Infant, Newborn, Diseases | 1 | 1971 | 587 | 0.020 |
Why?
|
| Surface Properties | 1 | 1989 | 1154 | 0.020 |
Why?
|
| Transplantation, Heterologous | 2 | 1984 | 2391 | 0.020 |
Why?
|
| Transcription Factor RelA | 1 | 2007 | 252 | 0.020 |
Why?
|
| Heart Septal Defects, Atrial | 2 | 1966 | 452 | 0.020 |
Why?
|
| Hedgehog Proteins | 1 | 2010 | 771 | 0.020 |
Why?
|
| Ligation | 2 | 1999 | 446 | 0.020 |
Why?
|
| Cations, Divalent | 2 | 1984 | 167 | 0.020 |
Why?
|
| Myopia | 1 | 2008 | 254 | 0.020 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 1991 | 976 | 0.020 |
Why?
|
| Follow-Up Studies | 4 | 2020 | 39317 | 0.020 |
Why?
|
| Liver Regeneration | 1 | 1987 | 214 | 0.020 |
Why?
|
| Molecular Weight | 2 | 1988 | 2168 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 1988 | 1729 | 0.020 |
Why?
|
| Ascitic Fluid | 1 | 1985 | 189 | 0.020 |
Why?
|
| Caspase 3 | 1 | 2007 | 730 | 0.020 |
Why?
|
| Antigens, Polyomavirus Transforming | 1 | 2006 | 256 | 0.020 |
Why?
|
| Proteinuria | 1 | 2008 | 613 | 0.020 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2005 | 425 | 0.020 |
Why?
|
| Melphalan | 1 | 2006 | 421 | 0.020 |
Why?
|
| Choline O-Acetyltransferase | 1 | 1985 | 156 | 0.020 |
Why?
|
| Cell Nucleus | 3 | 2007 | 2875 | 0.020 |
Why?
|
| Protein Transport | 1 | 2010 | 1944 | 0.010 |
Why?
|
| Azacitidine | 1 | 2006 | 336 | 0.010 |
Why?
|
| Limb Deformities, Congenital | 1 | 2006 | 136 | 0.010 |
Why?
|
| Dibutyryl Cyclic GMP | 1 | 1984 | 6 | 0.010 |
Why?
|
| Genes, Duplicate | 1 | 2004 | 31 | 0.010 |
Why?
|
| Abnormalities, Drug-Induced | 1 | 2007 | 337 | 0.010 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 1997 | 2538 | 0.010 |
Why?
|
| Antibodies | 1 | 1992 | 2419 | 0.010 |
Why?
|
| Microsomes | 1 | 2004 | 252 | 0.010 |
Why?
|
| Epididymis | 1 | 1986 | 227 | 0.010 |
Why?
|
| Cardiovascular Diseases | 1 | 2010 | 15645 | 0.010 |
Why?
|
| Hematoxylin | 1 | 1984 | 61 | 0.010 |
Why?
|
| Eosine Yellowish-(YS) | 1 | 1984 | 70 | 0.010 |
Why?
|
| Body Fluids | 1 | 1986 | 321 | 0.010 |
Why?
|
| Transplantation Immunology | 1 | 1986 | 537 | 0.010 |
Why?
|
| Theophylline | 1 | 1984 | 133 | 0.010 |
Why?
|
| Luminescent Proteins | 1 | 2007 | 839 | 0.010 |
Why?
|
| Cholesterol Side-Chain Cleavage Enzyme | 1 | 2003 | 28 | 0.010 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 1991 | 1801 | 0.010 |
Why?
|
| Informed Consent | 1 | 2010 | 1010 | 0.010 |
Why?
|
| Inhibin-beta Subunits | 1 | 2003 | 27 | 0.010 |
Why?
|
| Oligopeptides | 1 | 2009 | 1195 | 0.010 |
Why?
|
| Mesylates | 1 | 2003 | 37 | 0.010 |
Why?
|
| Receptors, Steroid | 1 | 1984 | 157 | 0.010 |
Why?
|
| Mercaptoethanol | 1 | 1983 | 61 | 0.010 |
Why?
|
| Pneumonia, Aspiration | 1 | 2005 | 145 | 0.010 |
Why?
|
| Cytokines | 1 | 1999 | 7446 | 0.010 |
Why?
|
| Twins, Monozygotic | 1 | 2005 | 471 | 0.010 |
Why?
|
| Review Literature as Topic | 1 | 2005 | 297 | 0.010 |
Why?
|
| Diseases in Twins | 1 | 2005 | 447 | 0.010 |
Why?
|
| Ureter | 3 | 1983 | 364 | 0.010 |
Why?
|
| Puberty | 2 | 1996 | 501 | 0.010 |
Why?
|
| Homozygote | 1 | 2008 | 1774 | 0.010 |
Why?
|
| Prostatic Neoplasms | 1 | 2006 | 11097 | 0.010 |
Why?
|
| Flutamide | 1 | 2003 | 95 | 0.010 |
Why?
|
| 3-Oxo-5-alpha-Steroid 4-Dehydrogenase | 1 | 2003 | 74 | 0.010 |
Why?
|
| Lymphocytes | 1 | 1991 | 2605 | 0.010 |
Why?
|
| Medroxyprogesterone Acetate | 1 | 1984 | 155 | 0.010 |
Why?
|
| Digestive System Diseases | 1 | 2005 | 152 | 0.010 |
Why?
|
| Antigens, CD | 1 | 2013 | 4032 | 0.010 |
Why?
|
| Fetal Blood | 1 | 1990 | 1361 | 0.010 |
Why?
|
| Feminization | 1 | 1982 | 19 | 0.010 |
Why?
|
| Oncogenes | 1 | 2008 | 1232 | 0.010 |
Why?
|
| Glottis | 1 | 1984 | 214 | 0.010 |
Why?
|
| Genome | 1 | 2011 | 1752 | 0.010 |
Why?
|
| Heart Septal Defects, Ventricular | 1 | 1966 | 477 | 0.010 |
Why?
|
| Intestines | 1 | 1992 | 1905 | 0.010 |
Why?
|
| Hydrolysis | 1 | 1984 | 645 | 0.010 |
Why?
|
| Chromatography, Gel | 1 | 1983 | 634 | 0.010 |
Why?
|
| Phosphoric Diester Hydrolases | 1 | 1983 | 205 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 2 | 1982 | 6226 | 0.010 |
Why?
|
| Fallopian Tube Neoplasms | 1 | 1985 | 329 | 0.010 |
Why?
|
| Heparitin Sulfate | 1 | 1984 | 223 | 0.010 |
Why?
|
| Megacolon | 2 | 1979 | 11 | 0.010 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2007 | 1058 | 0.010 |
Why?
|
| Urinary Catheterization | 1 | 1983 | 195 | 0.010 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2007 | 701 | 0.010 |
Why?
|
| Reproducibility of Results | 2 | 2011 | 20169 | 0.010 |
Why?
|
| Retrospective Studies | 3 | 2020 | 81659 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 1989 | 3093 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 2010 | 4616 | 0.010 |
Why?
|
| Receptors, Estrogen | 2 | 2000 | 2252 | 0.010 |
Why?
|
| Introns | 1 | 2004 | 965 | 0.010 |
Why?
|
| Receptors, LH | 1 | 2001 | 18 | 0.010 |
Why?
|
| MAP Kinase Kinase 2 | 1 | 2002 | 92 | 0.010 |
Why?
|
| Intestinal Mucosa | 2 | 1986 | 3043 | 0.010 |
Why?
|
| Killer Cells, Natural | 1 | 1991 | 2209 | 0.010 |
Why?
|
| Chromatography, Ion Exchange | 1 | 2002 | 292 | 0.010 |
Why?
|
| Digoxin | 1 | 1983 | 246 | 0.010 |
Why?
|
| Muscle, Smooth | 1 | 2005 | 930 | 0.010 |
Why?
|
| Urogenital Abnormalities | 1 | 1984 | 255 | 0.010 |
Why?
|
| Species Specificity | 1 | 1986 | 2412 | 0.010 |
Why?
|
| Cell Fusion | 1 | 1982 | 294 | 0.010 |
Why?
|
| Menotropins | 1 | 2001 | 41 | 0.010 |
Why?
|
| Coloring Agents | 1 | 1984 | 565 | 0.010 |
Why?
|
| Siblings | 1 | 2005 | 828 | 0.010 |
Why?
|
| Ganglia | 2 | 1978 | 86 | 0.010 |
Why?
|
| Calcium | 1 | 1994 | 5792 | 0.010 |
Why?
|
| Feedback, Physiological | 1 | 2003 | 481 | 0.010 |
Why?
|
| Ribonucleases | 1 | 2002 | 266 | 0.010 |
Why?
|
| Extracellular Matrix | 1 | 1989 | 1733 | 0.010 |
Why?
|
| Fatal Outcome | 1 | 2006 | 1836 | 0.010 |
Why?
|
| Dilatation | 1 | 1982 | 311 | 0.010 |
Why?
|
| Macromolecular Substances | 1 | 1983 | 1430 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2007 | 1405 | 0.010 |
Why?
|
| Concanavalin A | 1 | 1980 | 189 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2016 | 11217 | 0.010 |
Why?
|
| Nucleotides | 1 | 1983 | 454 | 0.010 |
Why?
|
| Circular Dichroism | 1 | 2001 | 333 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 1999 | 9410 | 0.010 |
Why?
|
| Fluorouracil | 1 | 1985 | 1652 | 0.010 |
Why?
|
| Smad5 Protein | 1 | 2000 | 26 | 0.010 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2002 | 330 | 0.010 |
Why?
|
| Germ-Line Mutation | 1 | 2008 | 1885 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 26325 | 0.010 |
Why?
|
| Cleft Palate | 1 | 2006 | 596 | 0.010 |
Why?
|
| Gene Dosage | 1 | 2004 | 1211 | 0.010 |
Why?
|
| Cross Reactions | 1 | 1982 | 828 | 0.010 |
Why?
|
| Plasminogen | 1 | 2000 | 144 | 0.010 |
Why?
|
| Immunosuppressive Agents | 3 | 1987 | 4210 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 1 | 1984 | 2472 | 0.010 |
Why?
|
| Eye | 1 | 1983 | 711 | 0.010 |
Why?
|
| Receptors, Drug | 1 | 1979 | 156 | 0.010 |
Why?
|
| Glycosaminoglycans | 1 | 1982 | 611 | 0.010 |
Why?
|
| Cisplatin | 1 | 1985 | 1656 | 0.010 |
Why?
|
| Thyrotropin | 1 | 1983 | 834 | 0.010 |
Why?
|
| Genes, Dominant | 1 | 2002 | 855 | 0.010 |
Why?
|
| Immunologic Techniques | 1 | 1999 | 213 | 0.010 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2001 | 423 | 0.010 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2000 | 279 | 0.010 |
Why?
|
| Hepatocyte Nuclear Factor 4 | 1 | 1999 | 127 | 0.010 |
Why?
|
| Cytotoxins | 1 | 1979 | 154 | 0.010 |
Why?
|
| Oxidation-Reduction | 1 | 2005 | 2221 | 0.010 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2001 | 694 | 0.010 |
Why?
|
| Cholinergic Fibers | 1 | 1978 | 68 | 0.010 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 1 | 1984 | 498 | 0.010 |
Why?
|
| Chromosome Disorders | 2 | 1984 | 498 | 0.010 |
Why?
|
| Protein Biosynthesis | 1 | 1986 | 2093 | 0.010 |
Why?
|
| Microinjections | 1 | 1999 | 319 | 0.010 |
Why?
|
| Perfusion | 1 | 1983 | 1409 | 0.010 |
Why?
|
| Preoperative Care | 1 | 1987 | 2252 | 0.010 |
Why?
|
| Endoderm | 1 | 1999 | 165 | 0.010 |
Why?
|
| Intubation, Intratracheal | 2 | 2005 | 1359 | 0.010 |
Why?
|
| Prolactin | 1 | 1980 | 627 | 0.010 |
Why?
|
| Biopsy, Needle | 1 | 1983 | 1615 | 0.010 |
Why?
|
| Temperature | 3 | 1993 | 2232 | 0.010 |
Why?
|
| Stimulation, Chemical | 1 | 1978 | 305 | 0.010 |
Why?
|
| Receptors, Androgen | 1 | 1984 | 1089 | 0.010 |
Why?
|
| Castration | 1 | 1977 | 149 | 0.010 |
Why?
|
| Embryonic Induction | 1 | 1998 | 152 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 1999 | 474 | 0.010 |
Why?
|
| Testicular Hydrocele | 1 | 1977 | 27 | 0.010 |
Why?
|
| Immune Sera | 1 | 1978 | 605 | 0.010 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2016 | 5389 | 0.010 |
Why?
|
| Postoperative Care | 1 | 1984 | 1480 | 0.010 |
Why?
|
| Massachusetts | 1 | 1990 | 8890 | 0.010 |
Why?
|
| Peptides | 1 | 2009 | 4348 | 0.010 |
Why?
|
| Colon, Sigmoid | 1 | 1977 | 124 | 0.010 |
Why?
|
| Lysosomes | 1 | 1983 | 937 | 0.010 |
Why?
|
| Hernia | 1 | 1977 | 67 | 0.010 |
Why?
|
| Laryngoscopy | 1 | 1982 | 714 | 0.010 |
Why?
|
| Tissue Extracts | 1 | 1977 | 139 | 0.010 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2007 | 2800 | 0.010 |
Why?
|
| Freezing | 1 | 1977 | 310 | 0.010 |
Why?
|
| Capillaries | 1 | 2000 | 755 | 0.010 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 1999 | 326 | 0.010 |
Why?
|
| DNA Fragmentation | 1 | 1997 | 238 | 0.010 |
Why?
|
| Phagocytosis | 1 | 1982 | 1526 | 0.010 |
Why?
|
| Prostate-Specific Antigen | 1 | 2006 | 2463 | 0.010 |
Why?
|
| Immunoglobulin G | 2 | 2006 | 4560 | 0.010 |
Why?
|
| Amino Acid Substitution | 1 | 2001 | 1743 | 0.010 |
Why?
|
| Veins | 1 | 1980 | 769 | 0.010 |
Why?
|
| RNA-Directed DNA Polymerase | 1 | 1997 | 222 | 0.010 |
Why?
|
| Family | 1 | 2007 | 3210 | 0.010 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2001 | 1168 | 0.010 |
Why?
|
| Oxytocin | 1 | 1980 | 403 | 0.010 |
Why?
|
| Cyclosporins | 2 | 1987 | 216 | 0.010 |
Why?
|
| Gene Targeting | 1 | 1999 | 841 | 0.010 |
Why?
|
| Rupture, Spontaneous | 1 | 1976 | 365 | 0.010 |
Why?
|
| Amino Acids | 3 | 1989 | 1712 | 0.010 |
Why?
|
| Vagus Nerve | 1 | 1978 | 458 | 0.010 |
Why?
|
| Drug Therapy, Combination | 2 | 1996 | 6310 | 0.010 |
Why?
|
| Transplantation, Autologous | 1 | 1980 | 2118 | 0.010 |
Why?
|
| Health Surveys | 1 | 2005 | 4056 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2020 | 54886 | 0.010 |
Why?
|
| Isoleucine | 1 | 1995 | 111 | 0.010 |
Why?
|
| Blood Proteins | 1 | 2000 | 1190 | 0.010 |
Why?
|
| Homeostasis | 1 | 1986 | 3345 | 0.010 |
Why?
|
| Ganglia, Sympathetic | 1 | 1995 | 65 | 0.010 |
Why?
|
| Phosphotransferases | 1 | 1996 | 302 | 0.010 |
Why?
|
| Aspergillosis | 1 | 1977 | 241 | 0.010 |
Why?
|
| Gases | 1 | 1975 | 205 | 0.010 |
Why?
|
| Mice, Mutant Strains | 1 | 1998 | 1751 | 0.010 |
Why?
|
| Androgen Antagonists | 1 | 2003 | 1412 | 0.010 |
Why?
|
| Mink | 1 | 1994 | 31 | 0.010 |
Why?
|
| Anesthesia, Inhalation | 1 | 1975 | 220 | 0.010 |
Why?
|
| Air Pressure | 1 | 1994 | 75 | 0.010 |
Why?
|
| Anal Canal | 1 | 1977 | 375 | 0.010 |
Why?
|
| Humidity | 1 | 1975 | 207 | 0.010 |
Why?
|
| Lung Diseases | 1 | 2005 | 1942 | 0.010 |
Why?
|
| Vitamin E | 1 | 1999 | 872 | 0.010 |
Why?
|
| Pesticides | 1 | 1997 | 297 | 0.010 |
Why?
|
| Endoscopy | 1 | 1984 | 1854 | 0.010 |
Why?
|
| Reoperation | 1 | 2005 | 4325 | 0.010 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 1985 | 2843 | 0.010 |
Why?
|
| Neurons | 2 | 1992 | 9517 | 0.010 |
Why?
|
| Hypothalamus | 1 | 1979 | 1002 | 0.010 |
Why?
|
| Phagosomes | 1 | 1995 | 194 | 0.010 |
Why?
|
| Ischemia | 2 | 1973 | 1905 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 1994 | 816 | 0.010 |
Why?
|
| Pulmonary Alveoli | 1 | 1996 | 665 | 0.010 |
Why?
|
| Adipose Tissue | 1 | 2005 | 3324 | 0.010 |
Why?
|
| Radioligand Assay | 1 | 1993 | 365 | 0.010 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2000 | 1493 | 0.010 |
Why?
|
| Bacterial Proteins | 1 | 2007 | 3834 | 0.010 |
Why?
|
| Fluorescein-5-isothiocyanate | 1 | 1993 | 220 | 0.010 |
Why?
|
| Iron | 1 | 1982 | 1811 | 0.010 |
Why?
|
| Intestinal Obstruction | 1 | 1977 | 433 | 0.010 |
Why?
|
| Embryonic Development | 1 | 1998 | 722 | 0.010 |
Why?
|
| Constriction, Pathologic | 1 | 1976 | 1104 | 0.010 |
Why?
|
| Mediastinal Emphysema | 1 | 1972 | 29 | 0.010 |
Why?
|
| Hepatectomy | 2 | 1987 | 589 | 0.010 |
Why?
|
| Sphingosine | 1 | 1994 | 306 | 0.010 |
Why?
|
| Recurrence | 1 | 2005 | 8504 | 0.010 |
Why?
|
| Hospitals | 1 | 2005 | 3883 | 0.010 |
Why?
|
| Nephrectomy | 2 | 1976 | 928 | 0.010 |
Why?
|
| Macaca fascicularis | 1 | 1994 | 908 | 0.010 |
Why?
|
| Renal Artery | 1 | 1973 | 355 | 0.010 |
Why?
|
| Intubation | 1 | 1972 | 140 | 0.010 |
Why?
|
| Membranes | 1 | 1991 | 164 | 0.010 |
Why?
|
| Oligonucleotide Probes | 1 | 1992 | 416 | 0.010 |
Why?
|
| Nucleic Acid Conformation | 1 | 1995 | 899 | 0.010 |
Why?
|
| DNA Probes | 1 | 1992 | 541 | 0.010 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2001 | 3684 | 0.010 |
Why?
|
| Testicular Neoplasms | 1 | 1977 | 806 | 0.010 |
Why?
|
| Cognition Disorders | 1 | 2005 | 3968 | 0.010 |
Why?
|
| Cross-Linking Reagents | 1 | 1993 | 689 | 0.010 |
Why?
|
| Tacrolimus | 1 | 1994 | 751 | 0.010 |
Why?
|
| Bronchoscopy | 1 | 1996 | 913 | 0.010 |
Why?
|
| Blood Gas Analysis | 1 | 1971 | 383 | 0.010 |
Why?
|
| Hypothermia | 1 | 1971 | 189 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 1993 | 2275 | 0.010 |
Why?
|
| Canada | 1 | 1995 | 2127 | 0.010 |
Why?
|
| Birth Weight | 1 | 1997 | 2122 | 0.000 |
Why?
|
| Prenatal Care | 1 | 1996 | 1158 | 0.000 |
Why?
|
| Leukemia | 1 | 1977 | 1518 | 0.000 |
Why?
|
| Endopeptidases | 1 | 1992 | 762 | 0.000 |
Why?
|
| Microcirculation | 1 | 1973 | 1282 | 0.000 |
Why?
|
| Endothelium, Vascular | 1 | 2000 | 4424 | 0.000 |
Why?
|
| Actuarial Analysis | 1 | 1987 | 370 | 0.000 |
Why?
|
| Infant, Premature | 1 | 1977 | 2125 | 0.000 |
Why?
|
| Placenta | 1 | 1976 | 1726 | 0.000 |
Why?
|
| Hospitals, Special | 1 | 1987 | 89 | 0.000 |
Why?
|
| Injections, Intraperitoneal | 1 | 1987 | 411 | 0.000 |
Why?
|
| Arteries | 1 | 1971 | 1123 | 0.000 |
Why?
|
| Brain | 1 | 1993 | 27163 | 0.000 |
Why?
|
| Postoperative Complications | 3 | 1987 | 15824 | 0.000 |
Why?
|
| Predictive Value of Tests | 1 | 2002 | 15424 | 0.000 |
Why?
|
| Iliac Artery | 1 | 1967 | 344 | 0.000 |
Why?
|
| Aminoglutethimide | 1 | 1985 | 13 | 0.000 |
Why?
|
| Norethindrone | 1 | 1985 | 56 | 0.000 |
Why?
|
| Severity of Illness Index | 1 | 2003 | 15925 | 0.000 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 1987 | 414 | 0.000 |
Why?
|
| Estrogen Antagonists | 1 | 1985 | 151 | 0.000 |
Why?
|
| Analysis of Variance | 1 | 1993 | 6215 | 0.000 |
Why?
|
| Heart Septal Defects | 1 | 1965 | 191 | 0.000 |
Why?
|
| Vanadates | 1 | 1984 | 82 | 0.000 |
Why?
|
| Vanadium | 1 | 1984 | 54 | 0.000 |
Why?
|
| Sodium Fluoride | 1 | 1984 | 67 | 0.000 |
Why?
|
| Saccharomyces cerevisiae | 1 | 1994 | 2678 | 0.000 |
Why?
|
| Regression Analysis | 1 | 1993 | 6331 | 0.000 |
Why?
|
| Azathioprine | 1 | 1985 | 354 | 0.000 |
Why?
|
| Cardiac Glycosides | 1 | 1983 | 29 | 0.000 |
Why?
|
| Quality of Life | 1 | 2005 | 13485 | 0.000 |
Why?
|
| Antilymphocyte Serum | 1 | 1985 | 490 | 0.000 |
Why?
|
| Femoral Artery | 1 | 1967 | 827 | 0.000 |
Why?
|
| Dimethyl Sulfoxide | 1 | 1984 | 250 | 0.000 |
Why?
|
| Pyrrolidines | 1 | 1985 | 339 | 0.000 |
Why?
|
| Seminiferous Tubules | 1 | 1982 | 25 | 0.000 |
Why?
|
| Alcian Blue | 1 | 1982 | 13 | 0.000 |
Why?
|
| Surgical Instruments | 1 | 1965 | 381 | 0.000 |
Why?
|
| H-Y Antigen | 1 | 1982 | 42 | 0.000 |
Why?
|
| Dysgerminoma | 1 | 1982 | 66 | 0.000 |
Why?
|
| Sulfur Radioisotopes | 1 | 1982 | 113 | 0.000 |
Why?
|
| Acute Disease | 1 | 1973 | 7236 | 0.000 |
Why?
|
| Growth Substances | 1 | 1985 | 759 | 0.000 |
Why?
|
| Societies, Medical | 1 | 1995 | 3964 | 0.000 |
Why?
|
| Metabolism, Inborn Errors | 1 | 1985 | 291 | 0.000 |
Why?
|
| Kidney Diseases | 1 | 1973 | 2099 | 0.000 |
Why?
|
| Prednisone | 1 | 1987 | 1566 | 0.000 |
Why?
|
| Pathology | 1 | 1965 | 270 | 0.000 |
Why?
|
| Hyaluronoglucosaminidase | 1 | 1982 | 138 | 0.000 |
Why?
|
| Antibody Affinity | 1 | 1983 | 251 | 0.000 |
Why?
|
| Tritium | 1 | 1982 | 707 | 0.000 |
Why?
|
| Manganese | 1 | 1985 | 393 | 0.000 |
Why?
|
| Heart Arrest | 1 | 1972 | 1516 | 0.000 |
Why?
|
| Sensitivity and Specificity | 1 | 1997 | 14672 | 0.000 |
Why?
|
| Myocardial Infarction | 1 | 1983 | 11513 | 0.000 |
Why?
|
| Autoradiography | 1 | 1982 | 725 | 0.000 |
Why?
|
| Sulfates | 1 | 1982 | 379 | 0.000 |
Why?
|
| Myosins | 1 | 1983 | 406 | 0.000 |
Why?
|
| Neoplasm Metastasis | 1 | 1992 | 4892 | 0.000 |
Why?
|
| Drug Combinations | 1 | 1987 | 2086 | 0.000 |
Why?
|
| Proline | 1 | 1982 | 454 | 0.000 |
Why?
|
| Thiophenes | 1 | 1985 | 570 | 0.000 |
Why?
|
| Tamoxifen | 1 | 1985 | 966 | 0.000 |
Why?
|
| Drug Interactions | 1 | 1985 | 1419 | 0.000 |
Why?
|
| Electrophoresis, Disc | 1 | 1979 | 66 | 0.000 |
Why?
|
| Hemorrhage | 1 | 1971 | 3464 | 0.000 |
Why?
|
| Heart Atria | 1 | 1965 | 1362 | 0.000 |
Why?
|
| Centrifugation, Density Gradient | 1 | 1979 | 297 | 0.000 |
Why?
|
| Chemoreceptor Cells | 1 | 1978 | 87 | 0.000 |
Why?
|
| Acid Phosphatase | 1 | 1977 | 141 | 0.000 |
Why?
|
| Carbohydrates | 1 | 1979 | 387 | 0.000 |
Why?
|
| Research | 1 | 1965 | 1977 | 0.000 |
Why?
|
| Growth | 1 | 1978 | 366 | 0.000 |
Why?
|
| Epitopes | 1 | 1983 | 2526 | 0.000 |
Why?
|
| Liver Diseases | 1 | 1985 | 1304 | 0.000 |
Why?
|
| Disseminated Intravascular Coagulation | 1 | 1977 | 187 | 0.000 |
Why?
|
| Pressure | 1 | 1979 | 1172 | 0.000 |
Why?
|
| Cystoscopy | 1 | 1976 | 128 | 0.000 |
Why?
|
| Reflex | 1 | 1977 | 375 | 0.000 |
Why?
|
| Thyroxine | 1 | 1978 | 666 | 0.000 |
Why?
|
| Nerve Fibers | 1 | 1978 | 706 | 0.000 |
Why?
|
| Tissue Donors | 1 | 1985 | 2387 | 0.000 |
Why?
|
| Cytoplasm | 1 | 1979 | 1504 | 0.000 |
Why?
|
| Nitrous Oxide | 1 | 1975 | 166 | 0.000 |
Why?
|
| Nerve Growth Factors | 1 | 1977 | 564 | 0.000 |
Why?
|
| Bronchial Diseases | 1 | 1975 | 151 | 0.000 |
Why?
|
| Boston | 1 | 1987 | 9360 | 0.000 |
Why?
|
| Wound Healing | 1 | 1965 | 2800 | 0.000 |
Why?
|
| Urinary Tract | 1 | 1976 | 305 | 0.000 |
Why?
|
| Body Temperature | 1 | 1975 | 780 | 0.000 |
Why?
|
| Liver | 1 | 1987 | 7578 | 0.000 |
Why?
|
| Skin | 1 | 1984 | 4499 | 0.000 |
Why?
|
| Intestine, Small | 1 | 1977 | 1217 | 0.000 |
Why?
|
| Glucose | 1 | 1982 | 4341 | 0.000 |
Why?
|
| Insulin | 1 | 1985 | 6602 | 0.000 |
Why?
|
| Respiratory Tract Diseases | 1 | 1975 | 744 | 0.000 |
Why?
|
| Treatment Outcome | 1 | 1996 | 65295 | 0.000 |
Why?
|
| Urinary Tract Infections | 1 | 1976 | 804 | 0.000 |
Why?
|
| Rabbits | 1 | 1975 | 4751 | 0.000 |
Why?
|
| Protein Kinase Inhibitors | 1 | 1985 | 5693 | 0.000 |
Why?
|
| Macrophages | 1 | 1979 | 5785 | 0.000 |
Why?
|
| Oxygen | 1 | 1975 | 4252 | 0.000 |
Why?
|
| Chronic Disease | 1 | 1977 | 9362 | 0.000 |
Why?
|